This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

23 May 2011

Sanofi Plots 2014 Launch of New Dengue Vaccine

Sanofi Pasteur plans to provide up to 100 million doses of the vaccine and has already begun construction on a manufacturing plant in France.

Sanofi Pasteur is hoping that its Phase III vaccine for the prevention of dengue fever in children and adults could hit the market by 2014, according to a Reuters report.


There are currently no approved cures or preventative vaccines for the disease, which is spread by mosquitoes. About 220 million people are infected each year and the disease can be fatal if it progress into the more serious hemorrhagic stage.


The vaccine is based on Sanofi's ChimeriVax technology. ChimeriVax is a live, a

Related News